These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 42489)

  • 21. [Problems in drug therapy of hypertension].
    Shkhvatsabaia IK; Erina EV
    Ter Arkh; 1974; 46(9):16-28. PubMed ID: 4155138
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparison of antihypertensive activity and tolerability of guanfacine and methyldopa.
    Malini PL; Strocchi E; Ambrosioni E; Magnani B
    Int J Clin Pharmacol Res; 1983; 3(1):35-9. PubMed ID: 6384071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of antihypertensive therapy on the quality of life.
    Croog SH; Levine S; Testa MA; Brown B; Bulpitt CJ; Jenkins CD; Klerman GL; Williams GH
    N Engl J Med; 1986 Jun; 314(26):1657-64. PubMed ID: 3520318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The clinical evaluation of prazosin, a new antihypertensive agent.
    Pitts NE
    Postgrad Med; 1975 Nov; Spec No():117-27. PubMed ID: 1105484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antihypertensive therapy with timolol and alpha-methyldopa. A double-blind trial in patients with moderately severe hypertension.
    Lubbe WF
    S Afr Med J; 1976 Feb; 50(9):279-85. PubMed ID: 4898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison between metoprolol and propranolol as antihypertensive agents. A double-blind cross-over study.
    Bengtsson C
    Acta Med Scand; 1976; 199(1-2):71-4. PubMed ID: 3094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The management of essential hypertension.
    O'Brien BW
    JAMA; 1974 Aug; 229(6):693-4. PubMed ID: 4408383
    [No Abstract]   [Full Text] [Related]  

  • 28. Commentary: calcium antagonist controversy, does the accusing finger also point to beta-blockers and methyldopa?
    Opie LH
    J Hum Hypertens; 1997 Apr; 11(4):201-4. PubMed ID: 9185023
    [No Abstract]   [Full Text] [Related]  

  • 29. Neuropsychological effects of antihypertensive drugs.
    Wurzelmann J; Frishman WH; Aronson M; Masur D; Ooi WL
    Cardiol Clin; 1987 Nov; 5(4):689-701. PubMed ID: 3454252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prazosin in hypertension: a double-blind evaluation with methyldopa and placebo.
    Mroczek WJ; Fotiu S; Davidov ME; Finnerty FA
    Curr Ther Res Clin Exp; 1974 Aug; 16(8):769-77. PubMed ID: 4217243
    [No Abstract]   [Full Text] [Related]  

  • 31. [Initial treatment of essential hypertension. Combination of a thiazide with methyldopa, and a beta-blocking agent with hydralazine].
    Lindholm J; Hansen OP; Hansen M
    Ugeskr Laeger; 1978 May; 140(19):1088-91. PubMed ID: 26134
    [No Abstract]   [Full Text] [Related]  

  • 32. Evaluation of the efficacy and safety of enalapril plus hydrochlorothiazide plus methyldopa vs standard triple therapy in the treatment of moderate to severe hypertension: results from a multicentre study.
    Leonetti G; Cuspidi C; Sampieri L; Ambrosioni E; Malini PL; Pessina A; Semplicini A; Cinotti G; Morabito S; Rappelli A
    J Hum Hypertens; 1990 Feb; 4(1):5-11. PubMed ID: 2189027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced peripheral vascular symptoms in elderly patients treated with alpha-methyldopa--a comparison with propranolol.
    VandenBurg MJ; Cooper WD; Woollard ML; Currie WJ; Bowker CH
    Eur J Clin Pharmacol; 1984; 26(3):325-9. PubMed ID: 6734693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blood lipid effects of antihypertensive therapy: a double-blind comparison of the effects of methyldopa and propranolol.
    Leon AS; Agre J; McNally C; Bell C; Neibling M; Grimm R; Hunninghake DB
    J Clin Pharmacol; 1984; 24(5-6):209-17. PubMed ID: 6747018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oslo study: treatment of mild hypertension. A five-year controlled drug study.
    Helgeland A; Leren P
    Nephron; 1987; 47 Suppl 1():108-10. PubMed ID: 3320783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic trials of pindolol in hypertension: comparison and combination with other drugs.
    Fanchamps A
    Am Heart J; 1982 Aug; 104(2 Pt 2):388-406. PubMed ID: 6125096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methyldopa and propranolol or practolol in moderate hypertension.
    Petrie JC; Galloway DB; Jeffers TA; Millar HR; Smith MC; Wood RA; Lewis JA; Simpson WT
    Br Med J; 1976 Jul; 2(6028):137-9. PubMed ID: 776350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of hypertension with an antihypertensive agent possessing vasodilator activity.
    Weber MA; Stokes GS
    Med J Aust; 1975 Jan; 1(SP2):9-11. PubMed ID: 1091822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is beta 1-antagonism essential for the antihypertensive action of beta-blockers?
    Vincent HH; Man in 't Veld AJ; Boomsma F; Derkx FH; Schalekamp MA
    Hypertension; 1987 Feb; 9(2):198-203. PubMed ID: 2880804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of timolol and propranolol in essential hypertension.
    Lohmöller G; Frohlich ED
    Am Heart J; 1975 Apr; 89(4):437-42. PubMed ID: 234668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.